Intact proteins can bind to class II histocompatibility molecules with high affinity

Molecular Immunology

Volumn 34, Issue 6, 1997, Pages 471-480

  Runnels, Herbert A ^a   Weber, Dominique A ^a   Moore, Joseph C ^a   Westerman, Larry E ^a   Jensen, Peter E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen processing; Class II histocompatibility molecules; HLA DM

Indexed keywords

HLA ANTIGEN CLASS 2; HLA D ANTIGEN; RIBONUCLEASE;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING;

ANIMALS; ANTIGEN-PRESENTING CELLS; BINDING SITES; CATTLE; DETERGENTS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HLA-DR ANTIGENS; HORSES; HUMANS; LIGANDS; MYOGLOBIN; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; RIBONUCLEASES;

BOVINAE; EQUUS CABALLUS;

EID: 0030822525     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00043-6     Document Type: Article

References (45)

1. Allen P. M. and Unanue E. R. (1984) Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immun. 132, 1077-1079.
2. Babbitt B. P., Allen P. M., Matsueda G., Haber E. and Unanue E. R. (1985) Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317, 359-361.
3. Bismuto E., Colonna G. and Irace G. (1983) Unfolding pathway of myoglobin. Evidence for a multistate process. Biochemistry 22, 4165-4170.
4. Brett S. J., Cease K. B. and Berzofsky J. A. (1988) Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing. J. Exp. Med. 168, 357-373.
5. Brown J. H., Jardestzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L. and Wiley D. C. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
6. Buus S., Sette A., Colon S. M., Jenis D. M. and Grey H. M. (1986) Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 41, 1071-1077.
7. Chang K. J., Jacobs S. and Cuatrecasas P. (1975) Quantitative aspects of hormone-receptor interactions of high affinity. Biochim. Biophys. Acta 406, 294-303.
8. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. and Strominger J. L. (1992) Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764-768.
9. Davidson H. W., Reid P. A., Lanzavecchia A. and Watts C. (1991) Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67, 105-116.
10. Deng H., Apple R., Clare-Salzler M., Trembleau S., Mathis D., Adorini L. and Sercarz E. (1993) Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. exp. Med. 178, 1675-1680.
11. Denzin L. K. and Cresswell P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
12. Fung-Leung W. P., Surh C. D., Liljedahl M., Pang J., Leturcq D., Peterson P. A., Webb S. R. and Karlsson L. (1996) Antigen presentation and T cell development in H2-M-deficient mice. Science 271, 1278-1281.
13. Germain R. N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
14. Germain R. N. and Hendrix L. R. (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353, 134-139.
15. Goto Y., Calciano L. J. and Fink A. L. (1990) Acid-induced folding of proteins. Proc. natn. Acad. Sci. U.S.A. 87, 573-577.
16. Hagerman P. J., Schmid F. X. and Baldwin R. L. (1979) Refolding behavior of a kinetic intermediate observed in the low pH unfolding of ribonuclease A. Biochemistry 18, 293-297.
17. Haughton G., Arnold L. W., Bishop G. A. and Mercolino T. J. (1986) The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1 + normal B cells. Immun. Rev. 93, 35-51.
18. Hughson F. M., Wright P. E. and Baldwin R. L. (1990) Structural characterization of a partly folded apomyoglobin intermediate. Science 249, 1544-1548.
19. Hunt D. F., Michel H., Dickinson T. A., Shabanowitz J., Cox A. L., Sakaguchi K., Appella E., Grey H. M. and Sette A. (1992) Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256, 1817-1820.
20. Jensen P. E. (1989) Stable association of processed antigen with antigen-presenting cell membranes. J. Immun. 143, 420-425.
21. Jensen P. E. (1991) Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174, 1111-1120.
22. Jensen P. E. (1992) Long-lived complexes between peptide and class II MHC are formed at low pH with no requirement for pH neutralization. J. Exp. Med. 176, 793-798.
23. Jensen P. E. (1993) Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immun. 150, 3347-3356.
24. Jensen P. E. (1995) Antigen unfolding and disulfide reduction in antigen presenting cells. Semin. Immun. 7, 347-353.
25. Lee P., Matsueda G. R. and Allen P. M. (1988) T cell recognition of fibrinogen. A determinant on the Aα-chain does not require processing. J. Immun. 140, 1063-1068
26. Linder R. and Unanue E. R. (1996) Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 59, 6910-6920.
27. Martin W. D., Hicks G. G., Mendiratta S. K., Leva H. I., Ruley H. E. and Van Kaer L. (1996) H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84, 543-550.
28. Miyazaki T., Wolf P., Tourne S., Waltzinger C., Dierich A., Barois N., Ploegh H., Benoist C. and Mathis D. (1996) Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84, 531-541.
29. Perkins D. L., Berriz G., Kamradt T., Smith J. A. and Gefter M. L. (1991) Immunodominance: intramolecular competition between T cell epitopes. J. Immun. 146, 2137-2144.
30. Roche P. A. (1995) HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity 3, 259-262.
31. Rodbard D. (1973) Mathematics of hormone - receptor interaction. Adv. Exp. med. Biol. 36, 289-326.
32. Rouas N., Christophe S., Housseau F., Bellet D., Guillet J. G. and Bidart J. M. (1993) Influence of protein-quaternary structure on antigen processing. J. Immun. 150, 782-792.
33. Rudensky A. Y., Preston-Hurlburt P., Hong S., Barlow A., Janeway C. A. Jr. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
34. Sercarz E. E., Lehmann P. V., Ametani A., Benichou G., Miller A. and Moudgil K. (1993) Dominance and crypticity of T cell antigenic determinants. Ann. Rev. Immun. 11, 729-766.
35. Sette A., Adorini L., Colon S. M., Buus S. and Grey H. M. (1989) Capacity of intact proteins to bind to MHC class II molecules. J. Immun. 143, 1265-1267.
36. Sherman M. A., Runnels H. A., Moore J. C., Stern L. J. and Jensen P. E. (1994) Membrane interactions influence the peptide binding behavior of DR1. J. Exp. Med. 179, 229-234.
37. Sherman M. A., Weber D. A. and Jensen P. E. (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
38. Sloan V. S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E. and Zaller D. M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
39. Stern L. J. and Wiley D. C. (1992) The human class II MHC protein HLA-DR1 assembles as empty ab heterodimers in the absence of antigenic peptide. Cell 68, 465-477.
40. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L. and Wiley D. C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
41. Streicher H. Z., Berkower I. J., Busch M., Gurd F. R. N. and Berzofsky J. A. (1984) Antigen conformation determines processing requirements for T cell activation. Proc. natn. Acad. Sci. U.S.A. 81, 6831-6835.
42. Tompkins S. M., Rota P. A., Moore J. C. and Jensen P. E. (1993) A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins. J. Immun. Meth. 163, 209-216.
43. Wang Y., Smith J. A., Gefter M. L. and Perkins D. L. (1992) Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes. J. Immun. 148, 3034-3041.
44. Weber D. A., Evavold B. D. and Jensen P. E. (1996) Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274, 618-620.
45. Wolf P. R. and Ploegh H. L. (1995) DM exchange mechanism. Nature 376, 464-465.